Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Oct
2
2010
Do You Know Who's Got Your Data? Poyner Spruill LLP
Jun
22
2011
Dealings with Vendors Shouldn't Expose Trade Secrets Poyner Spruill LLP
Nov
1
2009
A Cautionary Tale: Why Employers Must Define Acceptable Computer Use by Employees Bingham McCutchen LLP
Sep
16
2009
TRANSAMERICA LIFE FOUND TO INFRINGE “BUSINESS METHOD PATENT” ON VARIABLE ANNUITIES Clark Hill PLC
Sep
2
2012
Patent Reform – What You Need to Know for the Approaching September 16, 2012 Implementation Date Michael Best & Friedrich LLP
Nov
22
2015
Trans-Pacific Partnership and the Continuing Controversy Over the Exclusivity Period for Biologics Michael Best & Friedrich LLP
Dec
10
2015
Biologics and Biosimilars Bits and Bytes – December 10, 2015 Michael Best & Friedrich LLP
Jun
8
2013
Section 3(d) of the Indian Patents Act – Part I Michael Best & Friedrich LLP
Aug
29
2013
Section 8 of the Indian Patents Act and a Comparison with the Disclosure Requirements in Canada, Israel and the U.S. Michael Best & Friedrich LLP
Jan
15
2014
Time Period and Burden of Proof Requirements when Requesting Revocation of a Patent in Kenya Michael Best & Friedrich LLP
Jun
3
2016
An Overview of the USTR’s 2016 Special 301 Report on the State of IPR in Chile Michael Best & Friedrich LLP
Apr
10
2014
The Copaxone Story in the U.S. and India: A Further Update Michael Best & Friedrich LLP
Apr
23
2014
The Copaxone Story in the U.S. and India: To Stay or Not to Stay is the Question Michael Best & Friedrich LLP
Jun
30
2016
Overview of USTR’s 2016 Special 301 Report on State of Inter Partes Review in Argentina Michael Best & Friedrich LLP
Jul
13
2016
Federal Circuit Clarifies When an Invention is the Subject of a Commercial Sale or Offer for Sale for Purposes of the On-Sale Bar Michael Best & Friedrich LLP
Jun
20
2014
Availability of Biosimilar Pathways and Data/Marketing Exclusivity Globally: Update Michael Best & Friedrich LLP
Aug
28
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 8 of a 10-Part Series: Australia Michael Best & Friedrich LLP
Sep
22
2014
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 1 of a 5-Part Series Michael Best & Friedrich LLP
Oct
14
2014
First Mailbox Appeal to be decided by the Federal Court of Appeals in Brazil Michael Best & Friedrich LLP
Jun
27
2017
Federal Circuit Finds Inventor Testimony Inadequate to Establish A Common Inventive Entity Under 35 U.S.C. § 102(e) Michael Best & Friedrich LLP
Jan
22
2015
The Copaxone Story in the U.S. and India: U.S. Supreme Court Decision Michael Best & Friedrich LLP
Aug
28
2010
False Patent Marking – Case Law Update: Threshold “Standing” Inquiry Dooms False Marking Claims Asserted By Plaintiffs Who Do Not Allege a Concrete or Particularized Injury-In-Fact Michael Best & Friedrich LLP
Apr
2
2015
Pre- and Post-Grant Oppositions in India – Part 3 of an 8 Part Series Michael Best & Friedrich LLP
Apr
2
2011
New York Federal District Court Addresses the Pleading Standard and Constitutionality of False Patent Marking Claims Under 35 U.S.C. § 292 Michael Best & Friedrich LLP
Mar
22
2012
Supreme Court Rules that Certain Diagnostic Methods Based on Laws of Nature are not Patent-Eligible Michael Best & Friedrich LLP
Jul
14
2015
New Patent Examination Guidance in Canada for Evaluating Medical Diagnostic Methods: Will Canada’s Application Be More Flexible than the U.S.? Michael Best & Friedrich LLP
May
26
2012
Entrepreneur’s Guide to Intellectual Property – Blog Series: What Every Entrepreneur Should Know About U.S. Law and Patent System (Part 1) Michael Best & Friedrich LLP
Jun
6
2012
Entrepreneur’s Guide to Intellectual Property – Blog Series: Trade Secrets: What Are They and How Do I Protect Them? (Part 2) Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins